The prognostic value of YBX1, MED8, and KPNA2 in the HCC patient cohort was demonstrated by utilizing Kaplan‒Meier survival plots, resulting in encouraging outcomes (Fig. 7D). The gene discussed is YBX1; the disease is hepatocellular carcinoma.